ArticleOpen forum infectious diseases2024

Therapeutic Drug Monitoring of Long-Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection-A Case Series of Five Patients With One Virologic Failure After Development of Two-Class Resistance.

Jacob Gerstenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.